|Generate QR code
Open Access
Subscription Access
Nanoparticles in biology and medicine
https://doi.org/10.29235/1818-9857-2022-11-78-83
Abstract
The authors give characteristics of nanoparticles used in medicine and biology, consider the mechanisms of drug transport with their help, as well as research conducted at the Institute of Biophysics and Cell Engineering of the National Academy of Sciences of Belarus in this area.
About the Authors
A. Stanovaya
Институт биофизики и клеточной инженерии НАН Беларуси
Belarus
Belarus
M. Terekhova
Институт биофизики и клеточной инженерии НАН Беларуси
Belarus
Belarus
V. Abashkin
Институт биофизики и клеточной инженерии НАН Беларуси
Belarus
Belarus
M. Odabashi
Университет Аксарай
Turkey
Turkey
D. Shcherbin
Институт биофизики и клеточной инженерии НАН Беларуси
Belarus
Belarus
References
1. An Overview of the Applications of Nanomaterials and Nanodevices in the Food Industry / M. Shafiq [et al.] // Foods. 2020. Vol. 9, №2. P. 148.
2. E. Pérez-Herrero. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy / E. Pérez-Herrero, A. Fernández-Medarde // Eur. J. Pharm. Biopharm. 2015. Vol. 93. P. 52–79.
3. D. M. Moss. Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling / D. M. Moss, M. Siccardi // Br. J. Pharmacol. 2014. Vol. 171. №17. P. 3963–3979.
4. E. Samaridou. Lipid nanoparticles for nucleic acid delivery: Current perspectives / E. Samaridou, J. Heyes, P. Lutwyche // Adv. Drug. Deliv. Rev. 2020. Vol. 154–155. P. 37–63.
5. Chemistry of Lipid Nanoparticles for RNA Delivery / Y. Eygeris [et al.] // Acc. Chem. Res. 2022. Vol. 55. №1. P. 2–12.
6. D. A. Tomalia. In quest of a systematic framework for unifying and defining nanoscience / D. A. Tomalia // J. Nanopart. Res. 2009. Vol. 11. №6. P. 1251–1310.
7. How to study dendrimers and dendriplexes III. Biodistribution, pharmacokinetics and toxicity in vivo / D. Shcharbin [et al.] // J. Control. Release. 2014. Vol. 181, №1. P. 40–52.
8. Therapeutic nanoparticles for drug delivery in cancer / K. Cho [et al.] // Clin. Cancer Res. 2008. Vol. 14. №5. P. 1310–1316.
9. M. Wang. Targeting nanoparticles to cancer / M. Wang, M. Thanou // Pharmacol. Res. 2010. Vol. 62. №2. P. 90–99.
10. M. Rippe. Design of soft nanocarriers combining hyaluronic acid with another functional polymer for cancer therapy and other biomedical applications / M. Rippe, V. Cosenza, R. Auzély-Velty // Pharmaceutics. 2019. Vol. 11, №7. P. 338.
11. Carbon Nanotubes in Cancer Therapy and Drug Delivery / A. Elhissi [et al.] // Emerging Nanotechnologies in Dentistry. 2012. Vol. 2012. P. 347–363.
12. Nanomedicine therapeutic approaches to overcome cancer drug resistance / J. L. Markman [et al.] // Adv. Drug Deliv. Rev. 2013. Vol. 65. №13–14. P. 1866–1879.
13. Nanomaterials in combating cancer: Therapeutic applications and developments / S. Nazir [et al.] // Nanomedicine. 2014. Vol. 10. №1. P. 19–34.
14. R. K. Jain. Delivering nanomedicine to solid tumors / R. K. Jain, T. Stylianopoulos // Nat. Rev. Clin. Oncol. 2010. Vol. 7. №11. P. 653–664.
15. F. Danhier. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery / F. Danhier, O. Feron, V. Préat // J. Control. Release. 2010. Vol. 148. №2. P. 135–146.
16. Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress / T. Lammers [et al.] // J. Control. Release. 2012. Vol. 161. №2. P. 175–187.
17. E. Blanco. Principles of nanoparticle design for overcoming biological barriers to drug delivery / E. Blanco, H. Shen, M. Ferrari // Nat. Biotechnol. 2015. Vol. 33. №9. P. 941–951.
18. Y.H. Bae. Targeted drug delivery to tumors: Myths, reality and possibility / Y. H. Bae, K. Park // J. Control. Release. 2011. Vol. 153. №3. P. 198–205.
Review
For citations:
Stanovaya A., Terekhova M., Abashkin V., Odabashi M., Shcherbin D. Nanoparticles in biology and medicine. Science and Innovations. 2022;(11):78-83. (In Russ.) https://doi.org/10.29235/1818-9857-2022-11-78-83
Views: 474
Email this article 